THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTATION OF STANDARDIZED SEROLOGY TESTING FOR ITS INTE

Document text

Principal Investigator: lynn  briscoe
Organization: LEIDOS BIOMEDICAL RESEARCH, INC.
Fiscal Year: 2024
Award: $420,000
Funding agency: National Cancer Institute

The following support shall be provided for Therapeutic Development Branch:
• Continuation of the "Integrated Data Resource for Rare Diseases" working with Advanced Biomedical Computational Science at Leidos Biomedical Research, Inc.;
• Assay validation and non-GMP and GMP manufacturing of batches of drug substance and drug product;
• Stability studies to support projects with GMP and / or non-GMP products;
• Biodistribution / imaging and pharmacokinetic studies;
• Consulting services for development of bioanalytical methods;
• Regulatory services to support preclinical and / or clinical-stage projects;
• Electron microscopy studies;
• Gene expression and proteomic data analyses and cell-based screening studies;
• Proteomic profiling, cell-based efficacy studies, and clinical trials for canine comparative oncology;
• Laboratory animal support.

Terms: <Address><Assay><Bioassay><Biodistribution><Biological Assay><Biomedical Computing><Biomedical Research><COVID-19><CV-19><Canine Species><Canis familiaris><Cell Body><Cells><Clinical><Clinical Trials><CoV emergence><CoV pandemic><Computational Science><Coronavirus Infectious Disease 2019><Data Analyses><Data Analysis><Development><Dogs><Dogs Mammals><Drug Kinetics><Drugs><Electron Microscopy><Gene Expression><Image><Laboratory Animals><Medication><Methods><Oncology><Oncology Cancer><Orphan Disease><Pharmaceutical Preparations><Pharmacokinetics><Proteomics><Public Health><Rare Diseases><Rare Disorder><Serology test><Services><Standardization><Translational Research><Translational Science><Validation><biomedical computation><canine><comparative><corona virus emergence><coronavirus disease 2019><coronavirus disease-19><coronavirus emergence><coronavirus infectious disease-19><coronavirus pandemic><data integration><data interpretation><data resource><developmental><domestic dog><drug/agent><efficacy study><emergent CoV><emergent corona virus><emergent coronavirus><emerging CoV><emerging corona virus><emerging coronavirus><imaging><manufacture><nCoV><new CoV><new corona virus><new coronavirus><novel CoV><novel corona virus><novel coronavirus><orphan disorder><pre-clinical><preclinical><screening><screenings><serology assay><therapeutic agent development><therapeutic development><translation research><translational investigation><validations>